Vertex Pharmaceuticals Stock: Analyst Estimates & Ratings

Vertex Pharmaceuticals Incorporated (VRTX) is a leading U.S. biopharmaceutical company, headquartered in Boston, Massachusetts, deeply committed to discovering and developing transformative therapies for serious diseases. Vertex is best known for its pioneering work in cystic fibrosis (CF) with blockbuster drugs like Trikafta, Kalydeco, Orkambi, and others in its commercial portfolio. Beyond CF, its pipeline spans treatments for pain, sickle cell disease, kidney disorders, and type 1 diabetes. Vertex’s mar ...